Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | kinetoplastid kinetochore protein 10 | 0.0184 | 0.3712 | 1 |
Leishmania major | protein kinase, putative | 0.0184 | 0.3712 | 1 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 19, putative | 0.0184 | 0.3712 | 1 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0482 | 1 | 1 |
Echinococcus multilocularis | protein tyrosine kinase | 0.0257 | 0.5255 | 0.5255 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0482 | 1 | 1 |
Echinococcus multilocularis | dual specificity protein kinase clk2 | 0.0184 | 0.3712 | 0.3712 |
Schistosoma mansoni | tyrosine kinase | 0.0257 | 0.5255 | 0.5255 |
Echinococcus granulosus | casein kinase I gamma | 0.0062 | 0.112 | 0.112 |
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.0482 | 1 | 1 |
Echinococcus multilocularis | 0.018 | 0.3627 | 0.3627 | |
Schistosoma mansoni | serine/threonine protein kinase | 0.0184 | 0.3712 | 0.3712 |
Loa Loa (eye worm) | CMGC/SRPK protein kinase | 0.0055 | 0.0965 | 0.0965 |
Brugia malayi | Protein kinase domain containing protein | 0.026 | 0.5319 | 0.5319 |
Echinococcus granulosus | expressed protein | 0.0055 | 0.0965 | 0.0965 |
Entamoeba histolytica | protein kinase, putative | 0.0055 | 0.0965 | 0.5 |
Echinococcus multilocularis | casein kinase I gamma | 0.0062 | 0.112 | 0.112 |
Brugia malayi | Protein kinase domain containing protein | 0.0055 | 0.0965 | 0.0965 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0184 | 0.3712 | 0.3712 |
Echinococcus multilocularis | expressed protein | 0.0055 | 0.0965 | 0.0965 |
Plasmodium falciparum | protein serine/threonine kinase-1 | 0.0184 | 0.3712 | 1 |
Giardia lamblia | Kinase, CMGC CLK | 0.0184 | 0.3712 | 1 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 10, putative | 0.0184 | 0.3712 | 1 |
Echinococcus granulosus | hypothetical protein | 0.018 | 0.3627 | 0.3627 |
Trypanosoma brucei | kinetoplastid kinetochore protein 19 | 0.0184 | 0.3712 | 1 |
Loa Loa (eye worm) | casein kinase | 0.0058 | 0.1035 | 0.1035 |
Loa Loa (eye worm) | TK/FAK protein kinase | 0.026 | 0.5319 | 0.5319 |
Echinococcus granulosus | dual specificity protein kinase clk2 | 0.0184 | 0.3712 | 0.3712 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0062 | 0.112 | 0.112 |
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.0482 | 1 | 1 |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.0482 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0482 | 1 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0062 | 0.112 | 0.112 |
Plasmodium vivax | serine/threonine kinase-1, putative | 0.0184 | 0.3712 | 1 |
Leishmania major | protein kinase, putative | 0.0184 | 0.3712 | 1 |
Loa Loa (eye worm) | CMGC/CLK protein kinase | 0.0184 | 0.3712 | 0.3712 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 19, putative | 0.0184 | 0.3712 | 1 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 10, putative | 0.0184 | 0.3712 | 1 |
Echinococcus granulosus | protein tyrosine kinase | 0.0257 | 0.5255 | 0.5255 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0184 | 0.3712 | 0.5 |
Toxoplasma gondii | cell-cycle-associated protein kinase CLK, putative | 0.0184 | 0.3712 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0055 | 0.0965 | 0.0965 |
Entamoeba histolytica | protein kinase, putative | 0.0055 | 0.0965 | 0.5 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.0482 | 1 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0184 | 0.3712 | 0.3712 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.3627 | 0.3627 |
Loa Loa (eye worm) | protein kinase domain-containing protein | 0.0062 | 0.112 | 0.112 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Reduction (functional) | = 13 | Reduction in paw swelling at 100 mg/kg po dose in rat using adjuvant arthritis test. | ChEMBL. | 6620297 |
Relative potency (functional) | ND 0 | Potency relative to [2-(2,4-Dichloro-phenoxy)-phenyl]-acetic acid in rat adjuvant arthritis test;ND means no data. | ChEMBL. | 6620297 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.